Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy

Genes Immun. 2023 Dec;24(6):292-294. doi: 10.1038/s41435-023-00227-6. Epub 2023 Dec 11.

Authors

Ute E Burkhardt¹, Edward F Fritsch^{2

3

4}

Affiliations

¹ Accelerating Cancer Immunotherapy Research, Concord, MA, USA. [email protected].
² Accelerating Cancer Immunotherapy Research, Concord, MA, USA. [email protected].
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. [email protected].
⁴ Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].

PMID: 38082155
DOI: 10.1038/s41435-023-00227-6

No abstract available

Publication types

Comment

MeSH terms

CRISPR-Cas Systems
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Editing*
Humans
Immunotherapy
Neoplasms* / genetics
Neoplasms* / therapy